Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jonathan M Bernstein

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Oral Oncology|February 22, 2015
Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancerJonathan M Bernstein, Lucy E Kershaw, Stephanie B Withey, et al.
Head & Neck|April 12, 2017
Survival outcomes for cutaneous angiosarcoma of the scalp versus faceJonathan M Bernstein, Jonathan C Irish, Dale H Brown, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2017
Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance statusNatalie M Lowe, Jonathan M Bernstein, Kathleen Mais, et al.
Plos One|March 29, 2018
Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapyNatalie M Lowe, Lucy E Kershaw, Jonathan M Bernstein, et al.
The Journal of Laryngology and Otology|March 14, 2024
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth EditionJarrod J Homer, Stuart C Winter, Elizabeth C Abbey, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Oral Oncology|February 22, 2015
Tumor plasma flow determined by dynamic contrast-enhanced MRI predicts response to induction chemotherapy in head and neck cancerJonathan M Bernstein, Lucy E Kershaw, Stephanie B Withey, et al.
Head & Neck|April 12, 2017
Survival outcomes for cutaneous angiosarcoma of the scalp versus faceJonathan M Bernstein, Jonathan C Irish, Dale H Brown, et al.
Journal of Cancer Research and Clinical Oncology|December 10, 2017
Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance statusNatalie M Lowe, Jonathan M Bernstein, Kathleen Mais, et al.
Plos One|March 29, 2018
Pre-treatment tumour perfusion parameters and initial RECIST response do not predict long-term survival outcomes for patients with head and neck squamous cell carcinoma treated with induction chemotherapyNatalie M Lowe, Lucy E Kershaw, Jonathan M Bernstein, et al.
The Journal of Laryngology and Otology|March 14, 2024
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth EditionJarrod J Homer, Stuart C Winter, Elizabeth C Abbey, et al.
Pageof 2